Skip to main content
Caplight Logo









Farmalisto

Farmalisto

Private
BogotáHealthcare & Life Scienceshttps://farmalisto.com/en/home/

Last Round

Series B

Dec 23, 2020

Total Funding Raised

$18M

Company Overview

Farmalisto is a healthtech company that operates an online pharmacy platform providing medication delivery, telemedicine, and home care services in Latin America.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Telemedicine, Medical Devices, Pharma Supply Chain

Business Model

B2C

Customer Profile

Marketplace Commission, Services & Consulting

AI Layer

Non-AI

Keywords

online pharmacydigital pharmacytelemedicinee-commerce pharmacyhome healthcaree-healthtelehealthpharmacy deliverymedical suppliescorporate healthhealth marketplaceprescription deliverynursing servicesB2B pharmacy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Farmalisto Comparables

Compare Farmalisto with similar companies based on industry and business-model similarity.

Farmalisto comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prixz
83%
Farmacias del Ahorro
69%
Farmacias San Pablo
61%

Farmalisto Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 23, 2020
SeedMay 11, 2016

Key People

Founding team and executive leadership

Christian Carrasco Benavides

CEO Cofundador

Executive Team

Ricardo Rangel Saavedra

Group Chief Financial Officer

Executive Team

Farmalisto Investors

Notable investors and investment history

Farmalisto investors
InvestorRounds
Elysia CapitalSeed
IDB InvestSeries B
HBM Healthcare InvestmentsSeed, Series B
Cherry VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 23, 2020

    $18M round led by IDB Invest and HBM Healthcare Investments.

Farmalisto Filings

Explore SEC and related filing metadata, where available.

Farmalisto filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Farmalisto's valuation, stock price, and market status.

Is Farmalisto a public or private company?

Farmalisto is a private company.

What is the current stock price of Farmalisto?

Farmalisto is a private company with no public stock price. Caplight tracks Farmalisto's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Farmalisto worth (valuation)?

Valuation information for Farmalisto is not publicly available.

Can I buy Farmalisto stock?

Farmalisto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Farmalisto's last funding round?

Farmalisto's most recent funding round was Series B on December 23, 2020.

Who are the main investors in Farmalisto?

Key investors in Farmalisto include IDB Invest, HBM Healthcare Investments.

Will Farmalisto IPO soon?

No public IPO plans have been announced for Farmalisto.

How can I track Farmalisto secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Farmalisto's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBogotá
Employee Range102
Year Founded2013
Last FundingDec 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?